Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
As of today, Rhythm Pharmaceuticals(RYTM) shares are valued at $98.07. The company's market cap stands at 6.55B, with a P/E ratio of -31.60.
On 2026-02-14, Rhythm Pharmaceuticals(RYTM) stock traded between a low of $95.44 and a high of $100.99. Shares are currently priced at $98.07, which is +2.8% above the low and -2.9% below the high.
Rhythm Pharmaceuticals(RYTM) shares are trading with a volume of 738.56K, against a daily average of 769.93K.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $45.91 at its lowest and $122.20 at its peak.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $45.91 at its lowest and $122.20 at its peak.
RYTM News
Rhythm Pharmaceuticals (RYTM) announced an update on their ongoing clinical study. Rhythm Pharmaceuticals, Inc. is running a Phase 2 study called “A Randomized...